Nitroprusside how supplied storage and handling
| Nitroprusside |
|---|
| NITROPRESS® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Nitroprusside |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
How Supplied Storage and Handling
NITROPRESS (sodium nitroprusside injection) is supplied in amber-colored, single-dose 50 mg/2 mL Fliptop Vials (NDC 0409-3024-01).
Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]
To protect NITROPRESS from light, it should be stored in its carton until it is used.
Revised: 12/2013
EN-3406
Hospira, Inc., Lake Forest, IL 60045 USA[1]
References
- ↑ "NITROPRESS (SODIUM NITROPRUSSIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.]". Retrieved 27 February 2014.